A new mouse model with a working immune system could be used in laboratory research to improve understanding of Zika virus infection and aid development of new treatments, according to a study published in PLOS Pathogens.



Research Seminar - 'Doing PAR in Troubled Times' with Dr. Steven Jordan

TORONTO – September 1, 2016 – Ferring Canada, a subsidiary of Ferring Pharmaceuticals, is proud to announce a $2 million donation to McGill University in Montreal, Canada that will be used to create fellowships in health and health leadership, and to finance environmental research in the Canadian Arctic.
During a ceremony held August 29, 2016 at McGill University’s Faculty of Medicine, the School of Physical & Occupational Therapy (SPOT), in partnership with CBI-Concordia Physio Sport NDG, was officially recognized as a FIFA Medical Centre of Excellence. Joining the University of British Columbia as one of only two such sites accredited by FIFA in Canada, the primary focus of the Centre will be to educate the soccer community about different aspects of athletic performance from training principles, to nutrition and sport specific skills.
“The World Health Organization's (WHO) emergency committee on deadly yellow fever will meet on Aug. 31 to review outbreaks in Democratic Republic of Congo and Angola, a spokesman said on Tuesday, as a major vaccination campaigns continues.” (Reuters and The Washington Post)

Reducing opportunistic infections such as TB in children with HIV could save both lives and money

Research sheds new light on what constitutes healthy aging of the brain
The inability to remember details, such as the location of objects, begins in early midlife (the 40s) and may be the result of a change in what information the brain focuses on during memory formation and retrieval, rather than a decline in brain function, according to a study by McGill University researchers.

Research underlines importance of computational power in future neurological breakthrough
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.

Pioneering research at McGill’s Goodman Cancer Research Centre gets boost
The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients. The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of McGill University’s Rosalind and Morris Goodman Cancer Research Centre.

By Cynthia Lee, McGill Newsroom
Study of repeat drunk drivers, speeding offenders finds distinct behavioural profiles
Road crashes are the world’s leading cause of preventable death and injury in people under 35, accounting for around 5 million casualties every year. Repeat offenders make a disproportionate contribution to these statistics – and are known for their poor response to education and prevention efforts.

For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.

By Tod Hoffman, Lady Davis Institute
Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform

By Julie Robert, McGill University Health Centre
Millions of people today take statins to help lower their cholesterol level.